Cargando…
In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations
The membrane-anchored spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a pivotal role in directing the fusion of the virus particle mediated by the host cell receptor angiotensin-converting enzyme 2 (ACE-2). The fusion peptide region of the S protein S2 domain pr...
Autores principales: | Shekhar, Nishant, Sarma, Phulen, Prajapat, Manisha, Avti, Pramod, Kaur, Hardeep, Raja, Anupam, Singh, Harvinder, Bhattacharya, Anusuya, Sharma, Saurabh, Kumar, Subodh, Prakash, Ajay, Medhi, Bikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511214/ https://www.ncbi.nlm.nih.gov/pubmed/32963099 http://dx.doi.org/10.1128/mSystems.00382-20 |
Ejemplares similares
-
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2
por: Prajapat, Manisha, et al.
Publicado: (2020) -
Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD
por: Chauhan, Arushi, et al.
Publicado: (2021) -
Drug targets for corona virus: A systematic review
por: Prajapat, Manisha, et al.
Publicado: (2020) -
Virtual screening and molecular dynamics simulation study of approved drugs as a binder to the linoleic acid binding site on spike protein of SARS-CoV-2 and double mutant (E484Q and L452R)
por: Prajapat, Manisha, et al.
Publicado: (2022) -
Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
por: Sarma, Phulen, et al.
Publicado: (2020)